250 mg 893 Pill: white, capsule/oblong, 22mm
The pill with imprint 250 mg 893 (White, Capsule/Oblong, 22mm) has been identified as Temozolomide 250 mg and is used for Glioblastoma Multiforme, and Anaplastic Astrocytoma. It belongs to the drug class alkylating agents and is not a controlled substance.
Images for 250 mg 893
Temozolomide
- Imprint
- 250 mg 893
- Strength
- 250 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharma Global FZE
- National Drug Code (NDC)
- 47335-0893
- Inactive Ingredients
-
lactose anhydrous,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A corn,
shellac,
alcohol,
butyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
See also:
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.